Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 kB - PDF)

Bekijk

español (ES) (288.28 kB - PDF)

Bekijk

čeština (CS) (322.23 kB - PDF)

Bekijk

dansk (DA) (287.53 kB - PDF)

Bekijk

Deutsch (DE) (289.53 kB - PDF)

Bekijk

eesti (ET) (276.29 kB - PDF)

Bekijk

ελληνικά (EL) (335.21 kB - PDF)

Bekijk

français (FR) (289.25 kB - PDF)

Bekijk

hrvatski (HR) (307.68 kB - PDF)

Bekijk

latviešu (LV) (334.28 kB - PDF)

Bekijk

Malti (MT) (324.47 kB - PDF)

Bekijk

Nederlands (NL) (287.82 kB - PDF)

Bekijk

polski (PL) (380.69 kB - PDF)

Bekijk

português (PT) (288.12 kB - PDF)

Bekijk

română (RO) (482.45 kB - PDF)

Bekijk

slovenčina (SK) (324.97 kB - PDF)

Bekijk

slovenščina (SL) (318.42 kB - PDF)

Bekijk

suomi (FI) (285.73 kB - PDF)

Bekijk

svenska (SV) (287.15 kB - PDF)

Bekijk

Product information

български (BG) (936.84 kB - PDF)

Bekijk

español (ES) (457.64 kB - PDF)

Bekijk

čeština (CS) (695.23 kB - PDF)

Bekijk

dansk (DA) (443.55 kB - PDF)

Bekijk

Deutsch (DE) (456.17 kB - PDF)

Bekijk

eesti (ET) (460.88 kB - PDF)

Bekijk

ελληνικά (EL) (957.24 kB - PDF)

Bekijk

français (FR) (383.63 kB - PDF)

Bekijk

hrvatski (HR) (504.46 kB - PDF)

Bekijk

italiano (IT) (614.01 kB - PDF)

Bekijk

latviešu (LV) (750.12 kB - PDF)

Bekijk

lietuvių (LT) (673.01 kB - PDF)

Bekijk

magyar (HU) (1.07 MB - PDF)

Bekijk

Malti (MT) (774.79 kB - PDF)

Bekijk

Nederlands (NL) (445.92 kB - PDF)

Bekijk

polski (PL) (1.09 MB - PDF)

Bekijk

português (PT) (456.69 kB - PDF)

Bekijk

română (RO) (807.04 kB - PDF)

Bekijk

slovenčina (SK) (711.68 kB - PDF)

Bekijk

slovenščina (SL) (702.28 kB - PDF)

Bekijk

suomi (FI) (456.54 kB - PDF)

Bekijk

svenska (SV) (441.7 kB - PDF)

Bekijk

Íslenska (IS) (622.5 kB - PDF)

Bekijk

norsk (NO) (656.3 kB - PDF)

Bekijk
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 kB - PDF)

Bekijk

español (ES) (219.22 kB - PDF)

Bekijk

čeština (CS) (262.67 kB - PDF)

Bekijk

dansk (DA) (227.42 kB - PDF)

Bekijk

Deutsch (DE) (218.75 kB - PDF)

Bekijk

eesti (ET) (221.16 kB - PDF)

Bekijk

ελληνικά (EL) (268.37 kB - PDF)

Bekijk

français (FR) (221.14 kB - PDF)

Bekijk

hrvatski (HR) (227.55 kB - PDF)

Bekijk

italiano (IT) (191.92 kB - PDF)

Bekijk

latviešu (LV) (256.74 kB - PDF)

Bekijk

lietuvių (LT) (210.34 kB - PDF)

Bekijk

magyar (HU) (210.45 kB - PDF)

Bekijk

Malti (MT) (250.85 kB - PDF)

Bekijk

Nederlands (NL) (228.06 kB - PDF)

Bekijk

polski (PL) (245.92 kB - PDF)

Bekijk

português (PT) (231.37 kB - PDF)

Bekijk

română (RO) (434.62 kB - PDF)

Bekijk

slovenčina (SK) (253.67 kB - PDF)

Bekijk

slovenščina (SL) (237.31 kB - PDF)

Bekijk

suomi (FI) (204.11 kB - PDF)

Bekijk

svenska (SV) (218.51 kB - PDF)

Bekijk

Íslenska (IS) (185.95 kB - PDF)

Bekijk

norsk (NO) (222.67 kB - PDF)

Bekijk

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page